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Abstract  
Objective: The objective of this systematic review is to see how effective and safe is 
Acetyl-L-Carnitine in treating children with ADHD.  
 
Study Design: This systematic review evaluated 3 randomized, controlled and double 
blind articles all published in English, which were published in peer-reviewed journals. 
The articles were found on PubMed through PCOM’s library website.  
 
Outcomes measured: This review assessed how safe and effective ALC would be in 
treating children with ADHD. The outcomes were measured using the Parent and 
Teacher ADHD Scale IV, Conners’ Global Index-Parents Scale, Conners’ Global Index –
Teachers Scale and the Vineland scores as well. These scales measure the behavior and 
attention of the child. This study also measured side effects such as psychic, neurologic, 
autonomic and other side effects to determine how safe this medication was.  
 
Results: Based on all three studies conducted, it was determined that ALC combined 
with methylphenidate was ineffective in treating children with ADHD but it did prove to 
be safe and help to prevent side effects such irritability and headache. It was also 
determined that ALC alone without any other medications, was not effective and did not 
have a great impact on treating the behavior and attention of the children as well. The 
only significant finding showed that the children being treated with ALC alone were 
more prone to headaches compared to the group being treated with the placebo alone. 
However, ALC worked better in children with the inattentive type of ADHD compared to 
how it worked in children with the combined type of inattention and hyperactivity. ALC 
also worked very well to improve the symptoms of children with not only ADHD but 
also Fragile X Syndrome.      
 
Conclusion: In the end, it was determined that combined with methylphenidate, ALC 
would not be considered an effective treatment to help improve the behavior of children 
with ADHD. ALC used alone without any other medication was also determined to be 
ineffective in treating the behavior symptoms of ADHD. It was found that ALC actually 
might be more beneficial for treatment for a certain type of ADHD, like the inattentive 
type. ALC was proven to also have great improvement in the inattention and social skills 
of children, not only with ADHD, but also with Fragile X Syndrome and more studies 
could be done to see how well this would work in children with Autism.    
 
Key Words: “ADHD”, ”attention-deficit hyperactive disorder”, ”ALC”, “Acetyl-L-
Carnitine” 
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Introduction  
 Attention deficit hyperactivity disorder contains 3 categories, which include an 
inattentive type, an impulsive type and a hyperactive type.4 The inattentive type is used 
mostly to describe children who have trouble staying focused and are easily distracted.4 
The inattentive type might just walk away from responsibilities and tasks and they lack 
perseverance.5 Their work ethic may be all over the place due to the fact that they are 
disorganized. These children may also have behavior issues and may be defiant. They 
may also show a lack of comprehension of academics in school or a lack of 
comprehension of general things dealt with in life.5 Children with the inattentive type 
may also be forgetful and lose things very easily, especially when they place something 
down because they may not be able to remember where they placed that item.4 The 
impulsive type is used to describe children who make careless decisions without putting 
much though into those decisions. They can act on a whim, in a way that is careless and 
may seem inpatient at times. They may also find it hard to wait their turn in school or 
when playing games with other people at school.4 The hyperactive type describes children 
who cannot sit still such as children who always fidget while seating down or who are 
restless.4 Restless behaviors can be displayed in ways such as tapping on the desk at 
school or talking during quiet time in school or climbing furniture at home.5  
In adults this can be displayed as the constant need to move or swing the legs 
back and forth.5 This may not allow the child to be able to sit still during class long 
enough to be beneficial.5 They always feel the need to move or walk around and these 
symptoms can manifest at home, school or anywhere else. 4 They always feel the need to 
move even if the place and time is not appropriate.5 The impulsive type will make quick 
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decisions in the moment without thinking about the consequences affecting them or 
people around them. They may not even realize that some decisions they make carry a lot 
of harm that make impact their lives or the lives of others.4 They also assume if they 
make quick and fast decisions they will be rewarded and will receive instant 
gratification.5  
Teenagers with ADHD are more likely to have conflict with their friends, and 
tend to be more aggressive.4 They are more likely to become involved in crime, drink, 
smoke and use other drugs, which would further impact their decision making skills.4 
These children are not only impulsive in their actions but they also can be impulsive in 
their social interactions and conversations. These children may find that when conversing 
with other people, they tend to interrupt others while they are talking and they can also be 
intrusive.5 
People with ADHD may present with all of these types but may also present with 
one or two of these types.4 Some people may be affected by the inattentive type of 
ADHD, due to fact that they can’t stop daydreaming.4 The most common presentation of 
this condition is the inattentive type combined with the hyperactive behavior in older 
children.4 In younger children, such as preschool age, the hyperactive type may present 
first.4 It is expected that sometimes people may not be able to focus all the time or stop 
moving around, but if these behaviors get to the point where they interact with your 
quality of life, especially at home and at school, then it may be ADHD.5 Most people 
have this condition starting from a very young age but symptoms can change as people 
age and become older. Teenagers and adults with ADHD will be less hyperactive but will 
often feel restless.5                  
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 Scientists are unsure of what exactly causes this disorder and it’s symptoms but it 
has been proven that many things can lead to the development of this condition. In 
children with this condition, research has shown that low dopamine levels also affects the 
child and their learning abilities.7 The chemical is transported between the nerves of the 
cells in the brain, and is more used in the regions of the brain that deal with learning and 
memory.7 It has also been proven that our social environment can affect children too as 
well. ADHD can sometimes manifest from lack of exercise, huge emphasis on 
achievement and any change in the child’s family situation at home.7 Certain foods can 
play a role too in developing this, such as in children who eat many food containing 
artificial flavoring and preservatives.7  
Genes have proven to play a part in the development of this condition because 
ADHD can be hereditary.7 Any substance used during pregnancy can lead to an increased 
risk of the child developing ADHD such as cigarette smoking, alcohol use or controlled 
substance use. Any risk to fetus causing low birth weight, lack of oxygen at birth or brain 
injuries might cause this condition too.7 Exposure to environmental toxins such as high 
levels of lead, at a young age, can lead to this development as well.7 It has been shown 
that this condition is more common in males than females but this does not exclude the 
fact that females can get this condition too.4 If it does present in a female, they tend to 
have more issues with attention compared to being hyperactive.4 Many people with 
ADHD can also have other conditions associated with them such as various other type of 
learning disabilities, anxiety disorders, conduct disorders due to the impulsive behavior, 
depression, and substance abuse.4 
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 Unfortunately, the economic cost of ADHD is very high due to the fact that 9.5 % 
of children that are between the ages 4-17 years old have been diagnosed with ADHD.6 
27% of all the costs of ADHD are due to education and the healthcare associated with 
this condition.6 Children with ADHD need more attention in school, which leads to more 
education costs for programs such as special education, occupation and speech therapy 
and school counseling.6 These children also need more healthcare visits to adjust 
medications and monitor progress, which can cost up to 18.04 billion dollars total per 
year.6 First line medications are usually considered to be psychostimulants for this 
disorder.8 These stimulants include amphetamine-based drugs such as Dexedrine, 
Adderall and Vyvanse.8 Stimulants also include methylphenidate-based medications such 
as Ritalin (methylphenidate), Biphentin and Concerta.8  Non-stimulant drugs can be used 
as well such as Strattera (atomoxetine) and Intuniv (guanfacine) for patients that do not 
want to use stimulants or when stimulants fail.8           
Objective       
 The objective of this systematic review is to see how effective and safe is Acetyl-
L-Carnitine in treating children with ADHD.  
Methods 
 This systematic review evaluated 3 randomized, controlled and double blind 
articles all published in English, which were published in peer-reviewed journals. The 
articles were found on PubMed through PCOM’s library website. The articles were 
selected based on their time frame and how much the information in the articles could 
help answer my question. They were also selected on whether they discussed patient 
oriented evidence that matters (POEMs). The articles were found using the key words 
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“ADHD” and “Acetyl-L-Carnitine”. All patients in all 3 of the studies were over the age 
of 5 and under the age of 13 years, previously diagnosed with ADHD. The intervention 
used was Acetyl-l-Carnitine in weight based doses from 500 to 1500 mg b.i.d.  
In study conducted by Abbasi et al. from 2011, the first group was treated with 
acetyl-l-carnitine plus methylphenidate at a dose of 20 -30 mg/day depending on their 
weight. The second group was treated with just acetyl-l-carnitine at a dose of 20-30 
mg/day depending on their weight.  
In study conducted by Arnold et al. from 2007, the first group was treated with 
acetyl-l-carnitine at a dose of 500-1500 mg/day depending on weight while the second 
group was being treated with the placebo at a dose of 500-1500 mg/day depending on the 
weight.  
In study conducted by Torrioli et al. from 2008, the first group contained only 
boys aged 6 to 13 years old that had ADHD but also had Fragile X syndrome. They were 
treated with Acetyl –l- Carnitine at 500 mg twice daily while the second group had the 
same conditions but they were treated with a placebo at the same dose. P-values, 
ANOVA, t-values, standard deviations were used in the following articles.  
Table 1 –Demographics and characteristics of included studies  
Study  Type  #Pts Age 
(yrs)  
Inclusion 
criteria  
Exclusion 
criteria  
W/D Intervention  
Abbasi1 
(2011)  
Double 
blind 
RCT  
40 Between 
the ages 
of 7-13  
40 outpatients, 
which included 
28 boys and 12 
girls, between 
the ages of 7-
13 who met the 
DSM-IV-TR 
diagnostic 
criteria for 
ADHD  
Were excluded 
if they had a 
history or 
current 
diagnosis of 
pervasive 
developmental 
disorders, 
schizophrenia, 
or other 
psychiatric 
2 Methylphenidate 
plus Acetyl –l-
Carnitine   
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disorders.  
Arnold2 
(2007)  
Double 
blind 
RCT 
112 Ages 5 
to 12  
Confirmed by 
the Diagnostic 
Interview 
Schedule for 
children 
(DISC-IV); an 
item mean on 
either the 18 
DSM-IV 
ADHD 
symptoms  
Severe 
medical, 
surgical or 
neurological 
problems; 
anything that 
would 
interfere with 
treatment or 
assessment; a 
prior history of 
Carnitine 
therapy in the 
past three 
months prior 
to baseline  
31 Acetyl –l-
Carnitine   
Torrioli3 
(2008)  
Double 
blind 
RCT  
63 Ages 6 
– 13 
years  
Patients were 
recruited 
through genetic 
clinics and 
were included 
when their 
FXS diagnosis 
was confirmed 
by southern 
blot and they 
had ADHD   
Were not 
included in the 
study if they 
had disorders 
of central 
nervous 
system other 
than FXS, 
excluding 
epilepsy  
7 Acetyl –l-
Carnitine   
 
 
Outcomes  
 In study conducted by Abbasi et al. from 2011, the outcomes were measured 
using the Parent and Teacher ADHD Scale IV that has been used in Iran in school-age 
children. This scale measures the behavior and attention of the child and determines if it 
is abnormal. In this study, the behavior and attention of patients were assessed at baseline 
and then again at 21 days and then at 42 days after the medications were started. This 
study also measured side effects such as psychic, neurologic, autonomic and other side 
effects to determine how safe this medication was. The side effects were measured using 
the mean decrease in ADHD-RS-IV score that evaluates 18 symptoms of ADHD.    
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In the study conducted by Arnold et al. from 2007, a clinical evaluation was 
performed using the placebo or acetyl-l-carnitine for 16 weeks total. The children were 
evaluated at baseline, then at 8 weeks, then at 12 weeks and then again at 16 weeks using 
the Parent and Teacher Rated Scales. The behavior and attention was recorded as well as 
the safety measures including adverse reactions at 8, 12 and 16 weeks.  
In the study conducted by Torrioli et al. from 2008, an evaluation of the behavior 
and attention of boys with ADHD and Fragile X syndrome, was performed and they were 
treated with either the placebo or acetyl-l-carnitine. In this study, the assessment used to 
evaluate the boys was the Conners’ Global Index-Parents and Conners’ Global Index –
Teachers Scale. Results were also recorded from the Vineland scores as well. The boys 
that remained in the study were evaluated at baseline, then at 1 week, then at 6 weeks and 
then again at 12 weeks.  
Results   
 In study conducted by Abbasi et al. 2011, a trial was conducted using children and 
adolescents aged 7 to 13 years old. The total number of people in the study was 40 
patients, which included 28 boys and 12 girls, all of whom had ADHD.1 The dose of the 
methylphenidate and the Acetyl-L-Carnitine that the children were receiving was 
dependent on their weight. The doses of these medications ranged from 20 to 30 mg a 
day for the methylphenidate medication.1 In the first group, which was the group being 
treated with ALC and methylphenidate, one patient dropped out. In the second group, 
being treated with methylphenidate and the placebo, one patient also dropped out as well. 
In this study the principal measure that evaluated the behavior of the children was the 
Teacher and Parent attention deficit and hyperactivity disorder rating scale –IV.1 It was 
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proven in this study that overall the Acetyl – L- Carnitine did not make a difference in the 
behavior and attention of these children.1 It was shown that there was no difference 
between the two groups on the following scales. The side effects of ALC was also 
evaluated and it was shown that the group taking methylphenidate plus the placebo had 
more headaches and irritability than the group taking methylphenidate and ALC. The 
mean standard deviations scales were recorded and evaluated at baseline, and there was 
no difference between the two groups.1 As time went on, according to a one way repeated 
measures of analysis, the treatment that both groups were receiving did seem to greatly 
impact their behavior and attention on the Parent ADHD Rating Scale scores but the 
behavior between both groups was not that different.1 At the end of the study, the 
standard deviation for the Parent ADHD Rating Scale for the group receiving ALC and 
methylphenidate was -12.25± 9.86 and it was -10.35± 9.62 for the group receiving 
methylphenidate plus the placebo.1 The children were again evaluated at 6 weeks and it 
was determined that there was no difference in the behavior between the two groups 
again. It was also determined that there was no major difference in attention on the 
Teacher ADHD Rating Scale at baseline or at week 6 as well.1 Throughout the whole 
study, the behavior and the attention of both groups was very similar and did not change 
much between both groups, which lead to the results of the ALC not being effective.1 At 
the end of the study, the standard deviation for the Teacher ADHD Rating Scale scores 
for the group receiving ALC and methylphenidate was -7.90± 10.13 and it was -6.00± 
7.84 for the group receiving methylphenidate plus the placebo.1 This study did not only 
evaluate the effectiveness of the drug but also the side effects and safety. This study 
evaluated side effects such as abdominal pain, anxiety, decreased appetite, depression, 
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insomnia, weight loss, nausea, dry mouth, irritability, headaches, vomiting, fatigue, 
diarrhea, and dizziness. It was determined that the group receiving the methylphenidate 
and the placebo experienced more headaches and irritability.1 The group receiving 
methylphenidate and the placebo contained 19 people total and out of 19 patients, 18 of 
them experienced irritability, while 12 of them experienced headaches. 1 The value here 
was small. The NNH for the side effects, such as headaches was -3. That means for every 
3 patients treated with ALC, 1 fewer patient experienced side effects, such as headaches.	  
At the end of this study, it was determined that ALC plus methylphenidate helped to 
prevent side effects such as headaches and irritability.      
 In the study conducted by Arnold et al. 2007, the total number of participants was 
112 children, which contained 83 boys and 29 girls, aged 5 to 12 years old diagnosed 
with ADHD.2 The intent to treat analysis, 9 DSM-IV Teacher Rated Inattentive 
Symptoms Scale, determined that using ALC alone without any other medications, was 
not effective and did not have a great impact on the behavior and attention of the children 
in this study.2 Out of the 112 children that entered the study, only 92 children completed 
the assessment that took 8 weeks and 81 children completed the whole study.2 The 
primary outcome measure showed that ALC does help to improve the behavior and 
attention of the child but the results were not significant enough to consider this treatment 
successful. The primary outcome measure was the ITT outcome, which was the Teacher 
Rated Inattention Scale.2 Data from this primary outcome measure showed that there was 
no significant difference between the group taking the ALC and the group taking just the 
placebo. ITT analyses of secondary measure also reported finding the same results stating 
that there was not much of a difference between both groups as well. Another primary 
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outcome measure, known as the ADHD Inattentive Symptoms Scale, showed significant 
effects of ALC working well in children. According to these primary outcome measures, 
the ALC worked better in children with the inattentive type of ADHD compared to how it 
worked in children with the combined type of inattention and hyperactivity.2 This 
primary outcome measure reported a p-value of 0.02 for the group of children being 
treated with the ALC, which proved the data to be significant.2 This article also reported 
on the side effects of the ALC compared to the placebo. The side effects observed in the 
group being treated with ALC compared to the group being treated with the placebo, 
were not significant and were not different between the two groups.2 This article reported 
on side effects such as gastrointestinal disorders, headache, infections, cough, 
musculoskeletal disorders, metabolism and nutrition disorders, psychiatric disorders, 
poisoning, nasal congestion ands skin disorders. In the group of children being treated 
with ALC there was a total of 58 children but only 42 completed the trial out of this 
group.2 In the group being treated with the placebo, there were 60 children and only 39 
completed the trial.2 The NNH calculated was 10 patients. That means for every 10 
patients treated with ALC, 1 more patient experienced side effects, such as headaches. 
The value here is large. The only significant finding from the study showed that the 
children being treated with ALC were more prone to headaches compared to the group 
being treated with the placebo, which was the opposite of what was found in the study 
conducted by Abbasi et al. 2011.2  
In the study conducted by Torrioli et al. 2008, the objective of the results was to 
see if ALC would be effective in treating young boys with not only ADHD but also 
Fragile X Syndrome. 63 males entered the study and the study eventually ended with 7 
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patients dropping out leaving 56 patients to complete one year worth of treatment.3 The 
patients were evaluated at baseline, then at 1 month, then at 6 months and then again in 
12 months. In this study, according to the physicians’ ratings, it was determined that the 
ALC was safe to use in this population with a very low number of side effects being 
reported.3 This study used mean values and confidence intervals to record the data of both 
groups. According to the Conners’ Parents Scale, responsible for measuring 
inattentiveness, socialization and behavior, the score decreased 8 points in the group of 
children being treated with the ALC and 4.4 points in the group being treated with the 
placebo.3 The p-value recorded for this difference was 0.05, which was considered to be 
significant. Due to the fact that these scores decreased, this proved that the behavior and 
the inattentiveness of these young boys greatly improved.3 According to the Conners’ 
Teachers’ Scale, the score decreased as well by -6.2 points in the group being treated 
with ALC and -5.6 points in the group being treated with the placebo, in a 12 month 
period.3 This difference was considered insignificant due to the fact that this difference 
produced a p-value of 0.041.3 This insignificant finding was probably due to the fact that 
fewer teachers were able to respond to the questionnaires. The Vineland ABC and the 
Vineland Socialization Scales were also used as well and these scales help determine that 
the boys treated with ALC, had great improvements in their attention and socialization 
skills compared to the group of boys treated with just the placebo.3 The scores of the 
Vineland ABC and the Vineland Socialization Scales both increased but it increased 
more in the group being treated with ALC by +2.3 and +6.6 points respectively.3 In the 
group that contained the boys being treated with the placebo, they ended up losing all of 
their improved skills and actually fell well below their starting points.3 
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Discussion  
 ADHD is a disorder that is becoming more common but also is more recognized 
today as a condition that really affects a child’s ability to learn. Research suggest that one 
of the things that could lead to ADHD is the child’s ability to metabolize fatty acids and 
phospholipids, which are needed for brain development.1 It was shown that in children 
with ADHD, the levels of fatty acids are decreased in the plasma.1 ADHD is usually 
treated with stimulants, which are the first line medications but it is not guaranteed that 
these medications will always work. This urged scientists to find a different type of 
medication that can treat the problem instead of only treating the symptoms. Studies also 
show that diet and exercise play a big part in the development of ADHD and that needs to 
be addressed as well. It was proven that ALC can effect neurotransmitter metabolism by 
decreasing the glutamate dehydrogenase activity and increasing cytochrome oxidase 
activity.1 Because of this reason, the goal of study conducted by Abbasi et al. from 2011, 
was to prove that ALC can improve the metabolization of methylphenidate in children 
with ADHD. Unfortunately, according to the results of this study, it was proven that 
giving ALC along with methylphenidate was not helpful. But on the other hand, it was 
shown that children in the group treated with methylphenidate and ALC, were shown to 
have fewer side effects such as headaches and irritability than the group treated with the 
placebo and methylphenidate.1 Although, results in other studies were quite different 
showing that ALC decreased impulsive and hyperactive behavior in children.  
According to the study by Torrioli et al. 2008, the results showed that the ALC 
was effective towards improving the inattentive and social behavior in the male children 
with FXS.3 Although, it was proven that the ALC did not actually improve or increase the 
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intelligence of these boys.3 The children treated with the placebo also showed 
improvement but not nearly as much as the group treated with the ALC. Other therapies 
seem to help improve behavior too, along with the ALC, such as physical, speech and 
occupational therapy and support from teachers and parents.3 In this study, the ALC 
treatment helped to improve the hyperactive behavior but not enough to produce positive 
results and one reason for this could be due to the fact that only 34 patients were scored 
out of the 51.3 Since most of this study took place during the summer holiday months, 
some appointments to assess the children were missed. It was noticed that in the Vineland 
scores, the hyperactive group of children did well with the placebo during the first month 
but then afterwards the behavior started to worsen, probably due to the placebo effect.3 
The children, parents and teachers probably over estimated how well the drug would 
work in the first month and then started to notice that afterwards it just was not working 
at all.3         
According to study by Arnold et al. 2007, different malfunctions located in the 
brain can cause different types of ADHD. For example, research shows that the 
inattentive type is caused increased activation of the anterior cingulate and the middle 
frontal gyrus, which means there is a delay in the function of the thalamus.2 In other 
words, another study can be performed testing the ALC treatment with just children who 
have the inattentive type and this may produce better results. Other research shows the 
combined type is caused by the activation of the thalamus, putamen and insula, which 
would not benefit from ALC treatment.2 According to study by Torrioli et al. 2008, 
research shows that ALC can increase the synthesis of acetylcholine, which would also 
increase dopamine levels and various other amino acids needed for brain development.3        
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There are several factors that come into play that could have affected the results, 
such as short duration, small sample size, and doses of the medications used. 1,2,3 These 
results are very similar to the results of study by Arnold et al. 2007. In study by Arnold et 
al. 2007, it was proven that ALC was not effective in treating children with ADHD 
because it showed no difference in behavior in these children compared to the children 
being treated with the placebo.2 There are several factors that could play into the 
outcomes and one of them being which type of ADHD does the child have. It was proven 
that overall ALC was not an effective for ADHD treatment, however it was also proven 
that the ALC worked better in children with the inattentive type of ADHD and was more 
ineffective for children with the combined type.2,3 This study only included children of 
upper and middle class families, but it probably would have been beneficial to include 
children of lower class families as well to have better rounded results.2 Dosage of 
medications in this study could have affected the results as well. Patients could have been 
noncompliant with taking their medications, some medications could have been defective 
or there could have been miscalculation in the initial dosing.1,2,3  
There are also others factors that could have affected the results but not counted 
for in this study such as season, diet, culture and geographic location. Three sites located 
near the Eastern part of the Central Plains showed that the children being treated with the 
ALC showed improvement in behavior compared to the group being treated with the 
placebo.2 The other sites that were also included in this study showed results only 
opposite of this. In the group of children being treated with the ALC, it contained more 
children in the inattentive group compared to the combined group. In the group being 
treated with the placebo, it had an equal number of children in both the inattentive group 
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and the combined group.2 This variable in the number of children being treated with the 
ALC definitely could have played a part in the failure of this study, leading to an unfair 
advantage for the placebo.2  
 
Conclusion  
In the end, it was determined that combined with methylphenidate, ALC would 
not be considered an effective treatment to help improve the behavior of children with 
ADHD. ALC, however, was found to have beneficial effects in reducing side effects such 
as headaches and irritability. ALC used alone without any other medication was also 
determined to be ineffective in treating the behavior symptoms of ADHD. ALC was 
proven to have great improvement in the inattention and social skills of children, not only 
with ADHD, but also with Fragile X Syndrome.  
Further research can and should be explored, evaluating the effects ALC 
treatment in children with autism, who cannot tolerate stimulants. It was also determined 
that ALC is safe to use for treatment of ADHD without harmful side effects. In two out of 
the three articles discussed, it was found that ALC actually might be more beneficial for 
treatment for a certain type of ADHD, like the inattentive type. Further research should 
also be done exploring ALC as a potential treatment for children and adolescents, who 
only have the inattentive ADHD. There are many factors that could have a played a role 
in this failure in two out of the three studies, such as the sample size, location, economic 
status, dosage of medications, compliancy, and the measuring analysis.  
Research supports that one of the main reasons that cause inattentive ADHD was 
a decrease in the levels of fatty acids being produced and absorbed. This research 
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supports the theory that ALC can be used to help increase energy levels of these children 
that have the inattentive type of ADHD by stimulating lipid production or increasing the 
absorption of the lipids in different portions of the brain. It has also been found that this 
supplement can help increase levels of acetylcholine by increasing the cytochrome 
oxidase activity. With further research, ALC may be proven to improve the lives of 
children with the inattentive type of ADHD and other conditions such as autism.             
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   Dominique,	  ALC	  for	  ADHD	  	   19	  
References   
 
1. Abbasi S, Heidari S, Mohammadi M, Tabrizi M, Ghaleiha A, Akhondzadeh S. Acetyl-
L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity 
disorder in children and adolescents: A placebo-controlled trial. Child Psychiatry Hum 
Dev. 2011;42(3):367-375. http://www.ncbi.nlm.nih.gov/pubmed/21336630. doi: 
10.1007/s10578-011-0220-y. 
2. L Eugene Arnold, Antonino Amato, Hernan Bozzolo, et al. Acetyl-L-carnitine (ALC) 
in attention-deficit/hyperactivity disorder: A multi-site, placebo-controlled pilot 
trial. Journal of child and adolescent psychopharmacology. 2007;17(6):791-
802. http://www.ncbi.nlm.nih.gov/pubmed/18315451. doi: 10.1089/cap.2007.018. 
3. Torrioli MG, Vernacotola S, Peruzzi L, et al. A double-­‐‑blind, parallel, multicenter 
comparison of l-­‐‑acetylcarnitine with placebo on the attention deficit hyperactivity 
disorder in fragile X syndrome boys. American Journal of Medical Genetics Part A. 
2008;146A(7):803-
812. http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.32268/abstract. doi: 
10.1002/ajmg.a.32268. 
4. National Institute of Mental Health. Attention deficit hyperactivity 
disorder. https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-
adhd/index.shtml Web site. . Updated 2016. 5. Kuo FE, Faber Taylor A. A Potential Natural Treatment for Attention-
Deficit/Hyperactivity Disorder: Evidence From a National Study. American Journal of 
Public Health. 2004;94(9):1580-1586. 
 
6. The Natural Resource on ADHD. Cost of 
ADHD. http://www.chadd.org/Understanding-ADHD/About-ADHD/Data-and-
Statistics/Cost-of-ADHD.aspx Web site. . Updated 2018. 
7. Canadian Agency for Drugs and Technologies in Health. Context and policy issues - 
adhd. . 2016. https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0086230/. 8. Matza LS, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost 
effectiveness and resource allocation  : C/E. 2005;3:5. doi:10.1186/1478-7547-3-5. 
 
 
  
